Febbo William J
- SEC CIK
- 0001413987
No open-market purchases or sales filed in the past year.
Current role at each company
- MYO Myomo, Inc.Directoras of Jun 26, 2026
- OPRX OptimizeRx CorpCEOas of Feb 20, 2025
- AUGX Augmedix, Inc.Directoras of Oct 4, 2024
- MODD Modular Medical, Inc.Directoras of Jul 5, 2023
- LFMD LifeMD, Inc.Director, Other: Consultantas of Jun 22, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Febbo William J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
OPRX OptimizeRx Corp
CEO9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 (view filing) | Dec 12 | 4 days | Febbo William JCEO | PPurchase | +20.0K | $5.01 | +$100.2K | +3.4%601.3K after | |
| Aug 23, 2022 (view filing) | Aug 19-22 | 4 days | Febbo William JCEO | PPurchase | +16.1K | $15.59 | +$251.0K | +3.6%461.8K after | 2 lots |
| Feb 23, 2022 (view filing) | Feb 18 | 5 days | Febbo William JCHIEF EXECUTIVE OFFICER | SSale | −16.7K | $43.73 | −$728.8K | −3.6%445.7K after | 3 lots |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Febbo William JCHIEF EXECUTIVE OFFICER | SSale | −16.7K | $47.27 | −$787.8K | −3.5%462.3K after | 3 lots |
| Dec 17, 2021 (view filing) | Dec 15 | 2 days | Febbo William JCHIEF EXECUTIVE OFFICER | SSaleCommon Stock (pursuant to 10B5-1 plan) | −16.7K | $54.55 | −$909.1K | −3.4%469.4K after | |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Febbo William JCHIEF EXECUTIVE OFFICER | SSaleCommon Stock (pursuant to 10B5-1 plan) | −16.7K | $82.18 | −$1.37M | −3.3%486.0K after | |
| Oct 19, 2021 (view filing) | Oct 15 | 4 days | Febbo William JCHIEF EXECUTIVE OFFICER | SSaleCommon Stock (pursuant to 10B5-1 plan) | −16.7K | $84.20 | −$1.40M | −3.2%502.7K after | |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Febbo William JCHIEF EXECUTIVE OFFICER | SSaleCommon Stock (pursuant to 10B5-1 plan) | −16.7K | $65.74 | −$1.10M | −3.1%519.4K after | |
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Febbo William JCHIEF EXECUTIVE OFFICER | SSaleCommon Stock (pursuant to 10B5-1 plan) | −16.7K | $60.46 | −$1.01M | −3.0%544.6K after |
AUGX Augmedix, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2022 (view filing) | May 27 | Same day | Febbo William JDirector | PPurchase | +30.0K | $1.99 | +$59.7K | +51.4%88.4K after |
MODD Modular Medical, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2022 (view filing) | Feb 6 | 16 daysLate | Febbo William JDirector | PPurchase | +23.2K | – | – | –23.2K after | Derivative |